ESMO 2020: Melanoma highlights through an Australian lens

In this lively case-study based panel discussion, our multidisciplinary experts discuss the hot topics in melanoma from ESMO 2020 including the latest research in neoadjuvant therapy and brain metastases, and what they mean for clinical practice in Australia today.

This webinar was recorded as a partnership between the limbic and Melanoma Institute Australia. It is suitable for medical oncologists, surgical oncologists, radiation oncologists, surgeons and other healthcare professionals. .

HOST

Professor Georgina Long AO

Co-Medical Director, Melanoma Institute Australia

Chair, Melanoma Medical Oncology and Translational Research,

Melanoma Institute Australia and Royal North Shore Hospital,

The University of Sydney

PANELLISTS

Professor Grant McArthur

Executive Director, Victorian Comprehensive Cancer Centre | Consultant Medical Oncologist, Peter MacCallum Cancer Centre | Head, Molecular Oncology Laboratory and Cancer Therapeutics Program, Peter MacCallum Cancer Centre | Lorenzo Galli Chair of Melanoma and Skin Cancers, University of Melbourne

Professor Angela Hong

Radiation Oncologist, Melanoma Institute Australia.

Dr Thomas Pennington

Surgical Oncologist, Melanoma Institute Australia, Royal Prince Alfred Hospital and Northern Beaches Hospital

Dr Bringha Shivalingam

Director of Neurosurgery, The Chris O’Brien Lifehouse | Consultant Neurosurgeon, Royal Prince Alfred Hospital and The Mater Hospital

Associate, Melanoma Institute Australia